Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 32 | 34 | +2 |
| Shares | 3.17M | 2.95M | −226.2K (−7.1%) |
| Value | $30.4M | $17.6M | −$12.8M (−42.0%) |
New holders (8)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 38,400 | $227.0K | 0.00% |
| Brown Advisory Inc | 33,911 | $200.1K | 0.00% |
| Prime Capital Investment Advisors, LLC | 33,502 | $197.7K | 0.01% |
| Ergoteles LLC | 17,901 | $105.6K | 0.00% |
| Jane Street Group, LLC | 12,929 | $76.3K | 0.00% |
| Icon Wealth Advisors, LLC | 12,757 | $75.3K | 0.01% |
| Allworth Financial LP | 3,119 | $18.4K | 0.00% |
| FinTrust Capital Advisors, LLC | 75 | $442 | 0.00% |
Sold out (6)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Iowa State Bank | 18,862 | $181.0K |
| Jacobs Levy Equity Management, Inc | 18,712 | $179.0K |
| Citigroup Inc | 295 | $3.00K |
| China Universal Asset Management Co., Ltd. | 229 | $2.00K |
| BNP Paribas Arbitrage, SA | 151 | $1.45K |
| Daiwa Securities Group Inc. | 58 | $1.00K |